Literature DB >> 8798476

FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-beta receptors.

M J Charng1, P Kinnunen, J Hawker, T Brand, M D Schneider.   

Abstract

The FK506-binding protein, FKBP12, is a putative target of type I receptors for transforming growth factor-beta (TbetaR-I). As the FK506 motif that competes with TbetaR-I for FKBP12 resembles an invariant Leu-Pro dipeptide in TbetaR-I, we replaced Leu193 and Pro194 with Ala, along with mutations across the Gly/Ser box. L193A, P194A, and L193A/P194A do not alter TbetaR-I function; T204D partially activates, independent of ligand; L193A/P194A/T204D was an even more potent constitutive mutation. Association with FKBP12 in a yeast two-hybrid assay was disrupted by P194A, L193A/P194A, and L193A/P194A/T204D, but not L193A or T204D alone. Thus, FKBP12 recognition is dispensable for TGFbeta signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798476     DOI: 10.1074/jbc.271.38.22941

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Mechanisms of transforming growth factor-beta receptor endocytosis and intracellular sorting differ between fibroblasts and epithelial cells.

Authors:  J J Doré; D Yao; M Edens; N Garamszegi; E L Sholl; E B Leof
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

2.  A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.

Authors:  Celia L Gregson; Peter Hollingworth; Martin Williams; Kirsten A Petrie; Alex N Bullock; Matthew A Brown; Jon H Tobias; James T Triffitt
Journal:  Bone       Date:  2010-10-29       Impact factor: 4.398

3.  Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; David Danielpour
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

4.  A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.

Authors:  X H Feng; R Derynck
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

5.  FK506-binding protein 12 modulates μ-opioid receptor phosphorylation and protein kinase C(ε)-dependent signaling by its direct interaction with the receptor.

Authors:  Yu Qiu; Wei Zhao; Yan Wang; Jian-Rong Xu; Eddie Huie; Shan Jiang; Ying-Hui Yan; Horace H Loh; Hong-Zhuan Chen; Ping-Yee Law
Journal:  Mol Pharmacol       Date:  2013-10-10       Impact factor: 4.436

6.  Mechanism of TGFbeta receptor inhibition by FKBP12.

Authors:  Y G Chen; F Liu; J Massague
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

7.  Transcriptional activation of p21 by Tranilast is mediated via transforming growth factor beta signal pathway.

Authors:  Min-Ji Charng; Chieh-Hsi Wu
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 8.  FK506 and the role of immunophilins in nerve regeneration.

Authors:  B G Gold
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

9.  Specific activation of mitogen-activated protein kinase by transforming growth factor-beta receptors in lipid rafts is required for epithelial cell plasticity.

Authors:  Wei Zuo; Ye-Guang Chen
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

10.  Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.

Authors:  Peter M Siegel; Weiping Shu; Robert D Cardiff; William J Muller; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.